Xenon Pharmaceuticals News

Xenon Pharmaceuticals | DEF 14A: Definitive information statements

Apr 26 16:31 ET

Xenon Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 26 16:30 ET

Xenon Pharmaceuticals | 8-K: Current report

Apr 19 16:26 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Von Seggern Christopher

Mar 12 18:44 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer AULIN SHERRY

Mar 12 18:44 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KENNEY CHRISTOPHER JOHN

Mar 12 18:44 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer EMPFIELD JAMES R.

Mar 12 18:39 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN SHERRINGTON

Mar 12 18:39 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DiFabio Andrea

Mar 12 18:39 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MORTIMER IAN

Mar 12 18:34 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GAROFALO ELIZABETH A.

Mar 11 20:13 ET

Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 8 18:51 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN SHERRINGTON

Mar 8 17:36 ET

Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GANNON STEVEN

Mar 8 17:32 ET

Xenon Pharmaceuticals | 8-K: Current report

Mar 8 17:31 ET

Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 7 19:06 ET

Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 7 19:06 ET

Xenon Pharmaceuticals | 10-K: Annual report

Feb 29 22:33 ET

Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Feb 29 16:16 ET

Xenon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(7.7%),Behzad Aghazadeh(7.7%)

Feb 14 09:17 ET